119-HR-2715 Investigative Journalist Impact Analysis

Document 119‑HR‑2715: Scope and status

What the bill does and where it stands now.

• Expands FDA’s authority in 21 U.S.C. §381(a) from small‑value drugs/devices to “any article” refused admission that presents a “significant public health concern,” and adds a prohibited act for moving items FDA has decided to destroy. Effective 180 days after enactment; regulations due within 90 days. [1]Congress.gov — H.R. 2715 IH (Destruction of Hazardous Imports Act) — Congress.g…
• Current law lets HHS/FDA destroy, without export option, refused drugs/devices/tobacco products valued at $2,500 or less (subject to Treasury adjustment) with specified due‑process safeguards. [2]Legal Information Institute — 21 U.S. Code § 381 — Imports and exports (LII)
• House Energy & Commerce Committee reported the bill favorably (43–0) on May 21, 2026. [3]U.S. House of Representatives — House Energy & Commerce Committee Roll Call Vot…

Sources: FDA import‑refusal process; 21 U.S.C. §381(a); CFR background on import shares; CBP IPR statistics; bill text and committee vote. [4]U.S. Food & Drug Administration — Import Refusals — FDA

Summary

Neutral, evidence‑driven assessment of likely impacts.

The bill would likely accelerate removal of unsafe imports (e.g., falsified or hazardous FDA‑regulated goods) by letting FDA order destruction beyond today’s narrow, small‑value drug/device cases. Public‑health benefits are plausible given the scale of FDA‑regulated imports and documented risks in certain categories, but net effects depend on FDA’s rule defining “significant public health concern,” consistency with WTO obligations, and safeguards for due process. Short‑term, importers face higher compliance and disposal costs; longer‑term, incentives may shift toward stronger foreign supplier controls, while disposal volumes and associated emissions increase unless mitigated by waste‑management standards. [1]Congress.gov — H.R. 2715 IH (Destruction of Hazardous Imports Act) — Congress.g…

Economic Effects

Implications for firms, markets, and trade flows.

• Faster removal of unsafe goods can reduce downstream recall, liability, and health‑system costs by preventing entry into commerce, especially for high‑risk categories (e.g., unauthorized e‑cigarettes, certain medical products). Recent joint FDA/CBP actions illustrate material seizure volumes. [5]U.S. Department of Health and Human Services — HHS/CBP announce record seizures…
• Importer costs likely rise where reconditioning/export is denied and destruction is ordered: storage/handling, contractor fees, and potential liquidated damages for failures to redeliver to CBP. Destruction/export must occur within 90 days under CBP/FDA supervision. [4]U.S. Food & Drug Administration — Import Refusals — FDA
• Expanded destruction authority may deter marginal or non‑compliant suppliers and shift demand toward vetted foreign producers, raising compliance investment but potentially improving product quality assurance over time. (Inference based on FDA risk‑based import oversight.) [6]U.S. Food & Drug Administration — Inspections to Protect the Food Supply — FDA
• Duty‑drawback and CBP destruction‑under‑supervision rules can partially offset duty/tax losses when merchandise is destroyed, but they add administrative steps and documentation requirements. [7]govregs.com
• Trade‑exposure: More frequent destruction orders could trigger specific trade concerns if partners view measures as more trade‑restrictive than necessary; the bill’s directive to align with “applicable international agreements” (e.g., WTO SPS/TBT) aims to mitigate that risk. [1]Congress.gov — H.R. 2715 IH (Destruction of Hazardous Imports Act) — Congress.g…
• Market scale context: FDA‑regulated imports are extensive; about 15% of the U.S. food supply is imported (with >50% of fresh fruits and >90% of seafood), elevating stakes for efficient, accurate border decisions. [8]Council on Foreign Relations — What Is the FDA’s Role in Public Health?

Social Effects

Who benefits or bears risk across communities and demographics.

• Public‑health protection: Reducing entry of contaminated foods, falsified medicines, or unsafe devices can lower outbreak and injury risks. Historical CDC analyses show imported foods implicated in a subset of outbreaks as imports have grown. [9]Centers for Disease Control and Prevention (Emerging Infectious Diseases Journa…
• Consumer safety in e‑commerce channels: Destruction authority that reaches high‑risk consumer products (e.g., unauthorized nicotine devices) addresses harms that disproportionately affect youth and vulnerable users. [5]U.S. Department of Health and Human Services — HHS/CBP announce record seizures…
• Small importers and niche food businesses may face greater exposure to loss if compliant goods are misidentified or if reconditioning is disallowed; FDA’s process provides notice but refusals are final, with limited appeal pathways. [4]U.S. Food & Drug Administration — Import Refusals — FDA
• Equity considerations: Communities with higher dependence on imported specialty foods may experience sporadic supply disruptions if broader destruction authority is applied conservatively; conversely, they stand to benefit from reduced exposure to adulterated products. (Inference grounded in FDA import‑refusal mechanics and CDC outbreak evidence.) [4]U.S. Food & Drug Administration — Import Refusals — FDA

Environmental Effects

Sustainability, emissions, and waste‑management implications.

• Volume of waste may increase if more shipments are ordered destroyed rather than exported or reconditioned. Destruction is typically supervised by CBP/FDA; methods vary by material and contractor. [4]U.S. Food & Drug Administration — Import Refusals — FDA
• Air emissions from incineration: EPA’s 2026 updates to Hospital/Medical/Infectious Waste Incinerator (HMIWI) standards tighten controls on pollutants for relevant units, but added throughput still carries localized air‑quality impacts. [10]U.S. Environmental Protection Agency — Hospital/Medical/Infectious Waste Incine…
• For pharmaceuticals and similar wastes, EPA guidance recommends permitted hazardous‑waste combustors (incineration) as the most protective option—mitigating diversion but generating combustion emissions; applicability depends on waste type. [11]U.S. Environmental Protection Agency — Information for Law Enforcement Agencies…
• Persistent chemicals (e.g., PFAS) pose special disposal challenges; EPA’s 2024 interim guidance surveys destruction and disposal options and limitations, underscoring the need to route such streams to appropriate technologies. [12]epa.gov

Temporal Analysis

Short‑term versus long‑term consequences if enacted.

1. 0–6 months after enactment: FDA must finalize rules within 90 days; implementation begins 180 days after enactment. Expect initial uncertainty as “significant public health concern” is defined and field staff/brokers adjust procedures. [1]Congress.gov — H.R. 2715 IH (Destruction of Hazardous Imports Act) — Congress.g…
2. Near term (year 1): Border operations may see quicker case closure for refused high‑risk items, fewer opportunities for reconditioning/export in covered categories, and higher importer compliance costs tied to 90‑day destruction/export deadlines. [4]U.S. Food & Drug Administration — Import Refusals — FDA
3. Long term (2–5 years): Potential deterrence of non‑compliant exporters; improved average quality of FDA‑regulated imports; stable or reduced public‑health incidents tied to clearly targeted categories. Environmental loads from destruction persist unless offset by upstream compliance and best‑available waste‑handling technology. (Inference grounded in FDA risk‑based import oversight and EPA incineration controls.) [6]U.S. Food & Drug Administration — Inspections to Protect the Food Supply — FDA

Unintended Consequences and Risks

Secondary effects documented or reasonably foreseeable from past practice and the bill’s design.

• False positives and limited appeal: FDA refusals are final decisions with constrained avenues to rescind, raising stakes if destruction is ordered on borderline cases. [4]U.S. Food & Drug Administration — Import Refusals — FDA
• Supply chain shocks: If applied during peak seasons for imported produce/seafood, destruction orders could cause localized shortages or price spikes, though they may avert broader outbreak costs. (Inference using CDC import‑outbreak history.) [9]Centers for Disease Control and Prevention (Emerging Infectious Diseases Journa…
• Operational bottlenecks: CBP/FDA supervisory capacity for witnessing destruction within 90 days may be strained by higher volumes, risking storage congestion and liquidated‑damages exposure for importers awaiting appointments. [4]U.S. Food & Drug Administration — Import Refusals — FDA
• Waste‑management externalities: More incineration/landfill increases local environmental burdens unless routed to units meeting stringent standards and material‑specific guidance (e.g., pharma, PFAS). [10]U.S. Environmental Protection Agency — Hospital/Medical/Infectious Waste Incine…

Assessment

Bottom‑line analytical judgment (not advocacy).

• Overall stance: Neutral.
• Rationale: The authority is targeted at high‑risk imports and is supported by existing FDA/CBP processes, suggesting incremental public‑health gains. However, importer cost burdens, potential for erroneous destruction with limited appeal, added disposal externalities, and trade‑compliance sensitivities mean impacts are finely balanced and will depend on FDA’s rulemaking discipline and implementation fidelity to due‑process and WTO norms. [4]U.S. Food & Drug Administration — Import Refusals — FDA

Sourcing

Core references used for this assessment.

• Bill text and status: H.R. 2715 IH; House E&C Committee roll‑call (May 21, 2026). [1]Congress.gov — H.R. 2715 IH (Destruction of Hazardous Imports Act) — Congress.g…
• Current law and due‑process requirements: 21 U.S.C. §381(a) (imports and exports). [2]Legal Information Institute — 21 U.S. Code § 381 — Imports and exports (LII)
• FDA import‑refusal mechanics and timelines. [4]U.S. Food & Drug Administration — Import Refusals — FDA
• Scale and risk context: Imported‑food shares; FDA risk‑based oversight; CDC analyses of imported‑food outbreaks; ERS trends in pathogen‑based refusals. [8]Council on Foreign Relations — What Is the FDA’s Role in Public Health?
• CBP enforcement examples and market‑scale indicators (IPR seizures; unauthorized e‑cigarettes). [13]U.S. Customs and Border Protection — FY 2024 IPR Seizure Statistics — CBP
• Environmental controls and disposal guidance (incineration standards; pharma and PFAS waste). [10]U.S. Environmental Protection Agency — Hospital/Medical/Infectious Waste Incine…
• International‑agreement alignment (WTO SPS/TBT texts). [14]World Trade Organization — WTO Agreement on the Application of Sanitary and Phy…